Search Results - "Aspa, J."

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients by Rogado, J., Sánchez-Torres, J.M., Romero-Laorden, N., Ballesteros, A.I., Pacheco-Barcia, V., Ramos-Leví, A., Arranz, R., Lorenzo, A., Gullón, P., Donnay, O., Adrados, M., Costas, P., Aspa, J., Alfranca, A., Mondéjar, R., Colomer, R.

“…Cancer immune therapy has shown remarkable benefit in the treatment of a range of cancer types, although it may initiate autoimmune-related disorders in some…”
Get full text

Benign juvenile idiopathic epilepsy in captive Iberian lynx (Lynx pardinus) in the ex situ conservation program (2005-2019) by Mínguez, Juan J, El Bouyafrouri, Yasmin, Godoy, José A, Rivas, Antonio, Fernández, Jesús, Asensio, Victoria, Serra, Rodrigo, Perez-Aspa, María J, Lorenzo, Valentina

“…Benign juvenile idiopathic epilepsy has been described in humans but rarely in animals. The objectives of the study were to describe the clinical signs,…”
Get full text

Initial management of pneumonia and sepsis: factors associated with improved outcome by MENENDEZ, R, TORIES, A, DE CASTRO, F. R, RELLO, J, MOLINOS, L, RUIZ-MANZANO, J, REYES, S, ZALACAIN, R, CAPELASTEGUI, A, ASPA, J, BORDERIAS, L, MARTIN-VILLASCLARAS, J. J, BELLO, S, ALFAGEME, I

“…Processes of care and adherence to guidelines have been associated with improved survival in community-acquired pneumonia (CAP). In sepsis, bundles of…”
Get full text

PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B‐CELL LYMPHOMA by Callejas Charavia, M., Castilla García, L., Aspa, J., García Ramírez, P., Argüello Marina, M., Martínez Vázquez, C.

Get full text

Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome by Menéndez, R, Torres, A, Zalacaín, R, Aspa, J, Martín Villasclaras, J J, Borderías, L, Benítez Moya, J M, Ruiz-Manzano, J, Rodríguez de Castro, F, Blanquer, J, Pérez, D, Puzo, C, Sánchez Gascón, F, Gallardo, J, Álvarez, C, Molinos, L

“…Background: An inadequate response to initial empirical treatment of community acquired pneumonia (CAP) represents a challenge for clinicians and requires…”
Get full text

Community-acquired pneumonia in the elderly: Spanish multicentre study by Zalacain, R, Torres, A, Celis, R, Blanquer, J, Aspa, J, Esteban, L, Menendez, R, Blanquer, R, Borderias, L

“…Community-acquired pneumonia (CAP) in the elderly has increased as a consequence of an overall increase of the elderly population. A controversy about the…”
Get full text

Impact of initial antibiotic choice on mortality from pneumococcal pneumonia by Aspa, J, Rajas, O, Rodriguez de Castro, F, Huertas, M. C, Borderias, L, Cabello, F. J, Tabara, J, Hernandez-Flix, S, Martinez-Sanchis, A, Torres, A

“…To determine the impact of initial antimicrobial choice on 30-day mortality rate in patients with community-acquired pneumonia due to Streptococcus pneumoniae…”
Get full text

Reaching Stability in Community-Acquired Pneumonia: The Effects of the Severity of Disease, Treatment, and the Characteristics of Patients by Menéndez, Rosario, Torres, Antoni, Rodríguez de Castro, Felipe, Zalacaín, Rafael, Aspa, Javier, Martín Villasclaras, Juan J., Borderías, Luis, Benítez, José M. Moya, Ruiz-Manzano, Juan, Blanquer, José, Pérez, Diego, Puzo, Carmen, Sánchez-Gascón, Fernando, Gallardo, José, Álvarez, Carlos J., Molinos, Luis

“…Background. The natural history of the resolution of infectious parameters in patients with community-acquired pneumonia (CAP) is not completely known. The aim…”
Get full text

Crohn's disease, relapsing polychondritis and epidermolysis bullosa acquisita: an immune-mediated inflammatory syndrome by Vicente, E. F., Hernández-Núñez, A., Aspa, J., Aragües, M., García-Vicuña, R.

Get full text

PB2047: MOLECULAR DIAGNOSIS OF CONGENITAL ERYTHROCYTOSIS IN A SINGLE HOSPITAL CENTER by Castilla Garcia, L., Aspa Cilleruelo, J. M., Lopez de Hontanar Torres, G., Rodriguez Barquero, P. A., Sánchez Perez, R., Ayala Diaz, R., Ropero Gradilla, P., Martínez Nieto, J., González Fernández, A., Argüello Marina, M., Lopez Rubio, M.

Get full text

Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects by Ancochea, J, González, A, Sánchez, M J, Aspa, J, López-Botet, M

“…Cell surface phenotypes of bronchoalveolar lavage (BAL) and peripheral blood lymphocytes (PBL) obtained from a group of young healthy volunteers, including…”
Get more information

1287P Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy by Rogado, J., Pozo, F., Troulè, K., Sánchez-Torres, J.M., Laorden, N. Romero, Solís, R. Mondéjar, Candil, O. Donnay, García, A.I. Ballesteros, Pacheco-Barcia, V., Aspa, J., Al-Shahrour, F., Alfranca, A., Colomer, R.

Get full text

Characterization of a possible nosocomial aspergillosis outbreak by Mellado, E., Diaz-Guerra, T.M., Cuenca-Estrella, M., Buendia, V., Aspa, J., Prieto, E., Villagrasa, J.R., Rodriguez-Tudela, J. -L.

“…To study the epidemiologic aspects of a suspected outbreak of nosocomial invasive aspergillosis. Sixteen Aspergillus fumigatus strains were isolated from…”
Get full text

Evaluación final: ¿sirve el examen MIR? by Aspa Marco, Francisco J., Rodríguez de Castro, Felipe

Get full text

1287PExcess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients by Rogado, J, Laorden, N Romero, Torres, J M Sanchez, Ramos-Levi, A, Pacheco-Barcia, V E, Garcia, A I Ballesteros, Arranz, R, Lorenzo, A, Gullon, P, Garrido, A, Serra, J M, Donnay, O, Adrados, M, Costas, P, Aspa, J, Alfranca, A, Mondejar, R, Bosch, R Colomer

“…Abstract Background Immunotherapy is a new and effective form of therapy in several types of cancer, although molecular predictors of response are limited…”
Get full text

1287P - Excess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients by Rogado, J., Laorden, N Romero, Torres, J M Sanchez, Ramos-Levi, A., Pacheco-Barcia, V.E., Garcia, A I Ballesteros, Arranz, R., Lorenzo, A., Gullon, P., Garrido, A., Serra, J.M., Donnay, O., Adrados, M., Costas, P., Aspa, J., Alfranca, A., Mondejar, R., Bosch, R Colomer

“…Immunotherapy is a new and effective form of therapy in several types of cancer, although molecular predictors of response are limited. Recently, we have…”
Get full text

Excess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients by Rogado, J., Laorden, N Romero, Torres, J M Sanchez, Ramos-Levi, A., Pacheco-Barcia, V.E., Garcia, A I Ballesteros, Arranz, R., Lorenzo, A., Gullon, P., Garrido, A., Serra, J.M., Donnay, O., Adrados, M., Costas, P., Aspa, J., Alfranca, A., Mondejar, R., Bosch, R Colomer

Get full text

A95 ACUTE PNEUMONIA: CLINICAL STUDIES: Inflammation Biomarkers In Blood As Mortality Predictors In Community-Acquired Pneumonia Admitted Patients: Importance Of Neutrophil Count Percentage And Neutrophil-Lymphocyte Ratio by Marco, J Aspa, Curbelo, J, Luquero-Bueno, S, Roman, J Galvan, Ortega, M, Fernandez-Jimenez, G, Rajas, O, Vega-Piris, L, Rodriguez-Salvanes, F, Arnalich, B, Diez, A, Costa, R, De La Fuente, H, Lancho-Sanchez, A, Suarez, C, Ancochea, J

“…Blood analyses upon admittance (0-24 hours) and in the early stage (72-120 hours) were carried out, where C reactive protein, Procalcitonin, ProADM, Copeptin,…”
Get full text

Reconstitution of alveolar macrophages from donor marrow in allogeneic BMT; a study of variable number tandem repeat regions by PCR analysis of bronchoalveolar lavage specimens by Casado, L F, De la Camara, R, Granados, E, Giron, R, Aspa, J, Steegmann, J L

Get full text

Bronchoalveolar lavage cell composition in allogeneic bone marrow transplant patients without symptomatic lung complications by DE LA CAMARA, R, GIRON, R, MARRON, C, MARTINEZ, C, ANCOCHEA, J, FERNANDEZ-RANADA, J. M, ASPA, J

“…The purpose of this study was to assess the cytological composition of bronchoalveolar lavage (BAL) fluid in allogeneic BMT patients without lung complications…”
Get full text